Skip to main content

Clinical Update for Primary Care Team 9 February 2023

 1. Routine Covid-19 vaccination for people under 50 is ending

Adults under 50 in England have until 12 February 2023 to take up the NHS offer of a Covid-19 vaccination. After this date, only people in higher-risk groups under 50 are likely to be eligible for a Covid-19 vaccination. See https://www.bbc.co.uk/news/health-64496025

2. Medical examiner system

Implementation of the statutory medical examiner system will start from April 2023. Medical examiners are doctors who provide independent scrutiny of the causes of death. 

The purpose of the medical examiner system is to:

·         provide greater safeguards for the public by ensuring independent scrutiny of all non-coronial deaths

·         ensure the appropriate direction of deaths to the coroner

·         provide a better service for the bereaved and an opportunity for them to raise any concerns to a doctor not involved in the care of the deceased

·         improve the quality of death certification

·         improve the quality of mortality data

Medical examiners seek to answer three questions:

·         What caused the death of the deceased?

·         Does the coroner need to be notified of the death?

·         Was the care before death appropriate?

Medical examiners answer these by providing independent scrutiny, with three elements:

·         A proportionate review of relevant medical records

·         Interaction with the doctor completing the Medical Certificate of Cause of Death

·         Interaction with the bereaved, providing an opportunity to ask questions and to raise concerns

Implications for doctors completing death certificates:

·         Complete the death certificate accurately using the correct terms and sequence of causes.

·         Ensure the information in the deceased’s medical record supports the cause of death given on the death certificate.

See https://www.england.nhs.uk/establishing-medical-examiner-system-nhs/non-coronial-deaths-in-the-community/

3. Diagnosis and management of Monkeypox

An article published in the BMJ by myself and colleagues discusses the diagnosis and management of Monkeypox. See https://www.bmj.com/content/380/bmj-2022-073352

4. New NHS General Practice contract

Negotiations between the BMA’s GP Committee and NHS England about a new NHS General Practice contract in England have broken down, making it likely that NHS England will impose a contract unilaterally that the BMA views as unfavourable.

Comments

Post a Comment

Popular posts from this blog

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...
5 comments
Read more

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...
Post a Comment
Read more

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...
Post a Comment
Read more